Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data
Non-medical use of benzodiazepines and Z-drugs is common; however, there is limited information available on the extent of harm related to this in Europe, as well as the relationship between misuse and availability.
To describe presentations to the emergency department in Europe related to the recreational use of benzodiazepines and Z-drugs and compare regional differences in these presentations with legal drug sales of benzodiazepines and Z-drugs within each country.
Emergency department presentations with recreational misuse of benzodiazepines and Z-drugs were obtained from the Euro-DEN dataset for the period from October 2013 to September 2015; data extracted included demographics, clinical features, reported coused drugs, and outcome data. Sales figures obtained by QuintilesIMS™ (Atlanta, Georgia) were used to compare regional differences in the proportion of benzodiazepines and Z-drugs in the emergency department presentations and legal drug sales across Europe.
Over the 2 years, there were 2119 presentations to the Euro-DEN project associated with recreational use of benzodiazepines and/or Z-drugs (19.3% of all Euro-DEN presentations). Presentations with 25 different benzodiazepines and Z-drugs were registered in all countries, most (1809/2340 registered benzodiazepines and Z-drugs, 77.3%) of which were prescription drugs. In 24.9%, the benzodiazepine was not specified. Where the benzodiazepine/Z-drug was known, the most frequently used benzodiazepines and Z-drugs were respectively clonazepam (29.5% of presentations), diazepam (19.9%), alprazolam (11.7%), and zopiclone (9.4%). The proportions of types of benzodiazepines/Z-drugs related to ED-presentations varied between countries. There was a moderate (Spain, UK, Switzerland) to high (France, Ireland, Norway) positive correlation between ED presentations and sales data (Spearman Row’s correlation 0.66–0.80, p < 0.005), with higher correlation in countries with higher ED presentation rates.
Presentations to the emergency department associated with the non-medical use of benzodiazepines and/or Z-drugs are common, with variation in the benzodiazepines and/or Z-drugs between countries. There was a moderate to high correlation with sales data, with higher correlation in countries with higher ED presentation rates. However, this is not the only explanation for the variation in non-medical use and in the harm associated with the non-medical use of benzodiazepines/Z-drugs.
KeywordsAcute toxicity Benzodiazepine Z-drug Prescription Emergency department Euro-DEN
The Euro-DEN Project was funded by the DPIP/ISEC Programme of the European Union; all of the authors had funding from the European Commission through the Euro-DEN project except ML and EL, whose costs were co-funded by the Swiss Centre of Applied Human Toxicology (SCAHT), and BB, JG, ZM, and CL.
Compliance with ethical standards
Conflict of interest
PD and DW have received financial and statistical support to undertake population and web monitoring studies on the non-medical use of prescription and non-prescription medicines in the UK and Singapore and travel and honorarium costs to attend and present at the Annual RADARS International Symposium and Scientific Meeting from the RADARS System, Denver Health and Hospital Authority, Denver, US.
- 1.EMCDDA. Legal topic overviews: classification of controlled drugs. [Internet]. Lisbon; 2016. Available from: http://www.emcdda.europa.eu/html.cfm/index146601EN.html
- 3.BNF. Hypnotics and anxiolytics [Internet]. 2013 [cited 2017 Dec 12]. Available from: https://www.bnf.org
- 6.Home Office. The Misuse of Drugs Act 1971 (Modification) Order 2003. Br Med J. 2003;2–3. Available from: https://www.gov.uk/government/publications/controlled-drugs%2D%2D7
- 7.EMA. Zerene (zaleplon): Withdrawal of the marketing authorisation in the European Union. 2012Google Scholar
- 8.EMA. Sonata: withdrawal of the marketing authorisation in the European Union [Internet]. 2015. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2015/10/WC500195873.pdf
- 9.United Nations Office on Drugs and Crime. The non-medical use of prescription drugs Policy direction issues [Internet]. Vienna; 2011. Available from: http://www.unodc.org/docs/youthnet/Final_Prescription_Drugs_Paper.pdf
- 12.Zawertailo L, Busto U, Kaplan H, Greenblatt D, Sellers E (2003) Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. J Clin Psychopharmacol 23:269–280Google Scholar
- 16.EMCDDA. PERSPECTIVES ON DRUGS The misuse of benzodiazepines among high-risk opioid users in Europe [Internet]. 2015 [cited 2017 Jul 5]. Available from: http://www.emcdda.europa.eu/system/files/publications/2733/Misuse of benzos_POD2015.pdf
- 22.The National Center on, Abuse A and S. UNDER THE COUNTER: THE DIVERSION AND ABUSE OF CONTROLLED PRESCRIPTION DRUGS IN THE U.S. [Internet]. Columbia; 2005. Available from: https://www.centeronaddiction.org/addiction-research/reports/under-counter-diversion-and-abuse-controlled-prescription-drugs-us
- 23.Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE et al The European drug emergencies. Network (Euro-DEN)Google Scholar
- 25.European Monitoring Centre for Drugs and Drug Addiction. Hospital emergency presentations and acute drug toxicity in Europe [Internet]. 2016. Available from: http://www.emcdda.europa.eu/system/files/publications/2973/TD0216713ENN-1_Final pdf.pdf
- 26.Yamamoto T. Euro-DEN analysis on emergency department presentations related to benzodiazepine and heroin use.Google Scholar
- 27.Moeller KE, Lee KC KJ. Urine drug screening: practical guide for clinicians. 2008;7231:66–76Google Scholar
- 29.Schuermeyer J, Salomonsen-Sautel S, Price RK, Balan S, Thurstone C, Min SJ, Sakai JT (2014) Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003-11. Drug alcohol depend. [Internet]. Elsevier Ireland Ltd 140:145–155 Available from: https://doi.org/10.1016/j.drugalcdep.2014.04.016 Google Scholar
- 33.Heyerdahl F, Hovda KE, Giraudon I, Yates C, Dines AM, Sedefov R et al (2014) Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations. Clin Toxicol (Phila) 52:1005–1012Google Scholar